Bioxcel Therapeutics, Inc. · NASDAQ:BTAI
Mehta Vimal exercised options for 18,000 Bioxcel Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 7, 2026
On May 1, 2026, Mehta Vimal (Director, CEO and President) exercised options for 18,000 Bioxcel Therapeutics, Inc. shares, leaving 39,259 shares. Filed May 7, 2026 (Form 4).
- Options exercised
- 18,000 shares
- Holding after
- 39,259 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Option exercise | 18,000 | 39,259 | Direct |
Source
Related
- Bioxcel Therapeutics, Inc.
- Mehta Vimal
- Bioxcel Therapeutics, Inc. shareholders
- Form 4 · Mehta Vimal · Jun 17, 2026
- Form 4 · Mehta Vimal · May 22, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Rodriguez Javier · Jun 17, 2026
- Form 4 · Steinhart Richard I · Jun 17, 2026
- Form 4 · Yocca Frank · Jun 17, 2026
- Form 4 · Yocca Frank · May 22, 2026